Related references
Note: Only part of the references are listed.Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities
Rama Al Hamed et al.
BONE MARROW TRANSPLANTATION (2020)
The Epstein-Barr virus nuclear antigen-1 upregulates the cellular antioxidant defense to enable B-cell growth transformation and immortalization
Jiayu Wang et al.
ONCOGENE (2020)
High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi
Nathan D. Montgomery et al.
CANCER MEDICINE (2020)
Identification of the first cases of complete CD16A deficiency: Association with persistent EBV infection
A. Perez-Portilla et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
Susan Prockop et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
Eleni Anastasiadou et al.
LEUKEMIA (2019)
Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus-Positive and -Negative Relapsed or Refractory Non-Hodgkin Lymphomas
Seok-Jin Kim et al.
CANCER RESEARCH AND TREATMENT (2019)
CLINICAL OUTCOMES IN PATIENTS WITH EPSTEIN-BARR VIRUS (EBV)-POSITIVE NON-B CELL LYMPHOMA AT THE OHIO STATE UNIVERSITY JAMES COMPREHENSIVE CANCER CENTER (OSU JAMES CCC)
J.E. Brammer et al.
HEMATOLOGICAL ONCOLOGY (2019)
The whole-genome landscape of Burkitt lymphoma subtypes
Razvan I. Panea et al.
BLOOD (2019)
Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803/AMC-071 Trials
Polina Shindiapina et al.
BLOOD (2019)
Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era
Julien Lupo et al.
AIDS (2019)
Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4-and CD8-restricted epitopes as targets for T-cell immunotherapy
Mamta Kalra et al.
CYTOTHERAPY (2019)
Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085
Paul G. Rubinstein et al.
BLOOD (2019)
First data from a population based cancer registry in Ethiopia
Genebo Timotewos et al.
CANCER EPIDEMIOLOGY (2018)
Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone
James P. Dugan et al.
CLINICAL CANCER RESEARCH (2018)
A case-control study of HIV infection and cancer in the era of antiretroviral therapy in Rwanda
Tharcisse Mpunga et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma
Catherine M. Bollard et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Primary Epstein-Barr virus infection
Samantha K. Dunmire et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
Blood Epstein-Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma
Ikram Ul-Haq et al.
MEDICAL ONCOLOGY (2018)
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma
J. M. Connors et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2
Sana AlQarni et al.
ONCOGENE (2018)
Plasmablastic lymphoma in Malawi
Takondwa Zuze et al.
INFECTIOUS AGENTS AND CANCER (2018)
Regulatory T Cells As Potential Targets for HIV Cure Research
Adam J. Kleinman et al.
FRONTIERS IN IMMUNOLOGY (2018)
Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers
Maria Lina Tornesello et al.
CANCERS (2018)
Persistent peripheral blood EBV-DNA positive with high expression of PD-L1 and upregulation of CD4+CD25+T cell ratio in early stage NK/T cell lymphoma patients may predict worse outcome
Peng-fei Li et al.
ANNALS OF HEMATOLOGY (2018)
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation
Lauren P. McLaughlin et al.
BLOOD (2018)
Proteome-wide analysis of CD8+T cell responses to EBV reveals differences between primary and persistent infection
Calum Forrest et al.
PLOS PATHOGENS (2018)
Reduction of inflammation and T cell activation after 6months of cART initiation during acute, but not in early chronic HIV-1 infection
Hury Hellen Souza de Paula et al.
RETROVIROLOGY (2018)
Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV+ Patients
Diana M. Hernandez et al.
FRONTIERS IN IMMUNOLOGY (2018)
A longitudinal and cross-sectional study ofEpstein-Barr virus DNA load: a possible predictor of AIDS-related lymphoma in HIV-infected patients
S. H. Hijlkema et al.
INFECTIOUS DISEASES (2018)
BZLF1-DEC205 Fusion Protein Enhances EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease
Elshafa Hassan Ahmed et al.
BLOOD (2018)
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas
Erin G. Reid et al.
BLOOD ADVANCES (2018)
Epstein-Barr virus and regulatory T cells in Egyptian paediatric patients with acute B lymphoblastic leukaemia
Mohamed E. Ateyah et al.
JOURNAL OF CLINICAL PATHOLOGY (2017)
Epstein-Barr virus-associated lymphomas
Claire Shannon-Lowe et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
PI3Kδ activates E2F1 synthesis in response to mRNA translation stress
Sivakumar Vadivel Gnanasundram et al.
NATURE COMMUNICATIONS (2017)
Virus-Specific T Cells for the Immunocompromised Patient
Amy Houghtelin et al.
FRONTIERS IN IMMUNOLOGY (2017)
CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors
Yijie Ma et al.
CELL HOST & MICROBE (2017)
Suppression of EBV-induced LCLs using CAR T cells redirected against HLA-DR
Chungyong Han et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Impact of Plasmodium falciparum Coinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children
Arnold Reynaldi et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II
Laura L. Quinn et al.
JOURNAL OF VIROLOGY (2016)
Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival
Italo Tempera et al.
JOURNAL OF VIROLOGY (2016)
EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management
Jorge J. Castillo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial
Joseph C. Alvarnas et al.
BLOOD (2016)
Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing
Takanobu Tagawa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Repression of CIITA by the Epstein-Barr virus transcription factor Zta is independent of its dimerization and DNA binding
Nicolae Balan et al.
JOURNAL OF GENERAL VIROLOGY (2016)
T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment
Viviana Cobos Jimenez et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells
Manuel Albanese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Consideration of Epstein-Barr Virus-Encoded Noncoding RNAs EBER1 and EBER2 as a Functional Backup of Viral Oncoprotein Latent Membrane Protein 1
Kristina M. Herbert et al.
MBIO (2016)
PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model
Shi-Dong Ma et al.
PLOS PATHOGENS (2016)
Compartmentalization of Total and VirusSpecific Tissue-Resident Memory CD8+T Cells in Human Lymphoid Organs
Heng Giap Woon et al.
PLOS PATHOGENS (2016)
The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected Cells
Anna M. Gram et al.
PLOS PATHOGENS (2016)
Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T Cells
Antonia Pavlovic et al.
MEDICAL SCIENCE MONITOR (2016)
NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein-Barr Virus
Olivia Hatton et al.
FRONTIERS IN IMMUNOLOGY (2016)
Dynamic Perturbations of the T-Cell Receptor Repertoire in Chronic HIV Infection and following Antiretroviral Therapy
James M. Heather et al.
FRONTIERS IN IMMUNOLOGY (2016)
The tumor virus landscape of AIDS-related lymphomas
Aaron Arvey et al.
BLOOD (2015)
Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia
Xi Wang et al.
CELLULAR SIGNALLING (2015)
WWOX, large common fragile site genes, and cancer
Ge Gao et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Epstein-Barr Virus-Associated Lymphomas
Ewelina Grywalska et al.
SEMINARS IN ONCOLOGY (2015)
Elevation of Tim-3 and PD-1 Expression on T Cells Appears Early in HIV Infection, and Differential Tim-3 and PD-1 Expression Patterns Can Be Induced by Common γ-Chain Cytokines
Zi-Ning Zhang et al.
BIOMED RESEARCH INTERNATIONAL (2015)
The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development
Alex S. Hartlage et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Cellular Differentiation Regulator BLIMP1 Induces Epstein-Barr Virus Lytic Reactivation in Epithelial and B Cells by Activating Transcription from both the R and Z Promoters
Jessica A. Reusch et al.
JOURNAL OF VIROLOGY (2015)
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges
Paul G. Rubinstein et al.
AIDS (2014)
Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009
Sam M. Mbulaiteye et al.
APMIS (2014)
Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients
R. San-Juan et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
Catherine M. Bollard et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia
Lu Qian Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Epstein-Barr Virus BALF3 Has Nuclease Activity and Mediates Mature Virion Production during the Lytic Cycle
Shih-Hsin Chiu et al.
JOURNAL OF VIROLOGY (2014)
Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory
Alan B. Rickinson et al.
TRENDS IN IMMUNOLOGY (2014)
Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma
T. Zhang et al.
BLOOD CANCER JOURNAL (2014)
Behavioral, Virologic, and Immunologic Factors Associated With Acquisition and Severity of Primary Epstein-Barr Virus Infection in University Students
Henry H. Balfour et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Past, present and future: 30 years of HIV research
Francoise Barre-Sinoussi et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Demonstration of type II latency in T lymphocytes of Epstein-Barr Virus-associated hemophagocytic lymphohistiocytosis
Yoshinori Ito et al.
PEDIATRIC BLOOD & CANCER (2013)
Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection
Obinna Chijioke et al.
CELL REPORTS (2013)
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
Ekaterina Doubrovina et al.
BLOOD (2012)
Epstein-Barr Virus Infection and Expression of B-cell Oncogenic Markers in HIV-Related Diffuse Large B-cell Lymphoma
Chun Chao et al.
CLINICAL CANCER RESEARCH (2012)
Blood Epstein-Barr virus DNA load and risk of progression to AIDS-related systemic B lymphoma
M. Leruez-Ville et al.
HIV MEDICINE (2012)
Primary Epstein-Barr virus infection does not erode preexisting CD8+ T cell memory in humans
Oludare A. Odumade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells
Abu E. Rasul et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination
Simon Jochum et al.
PLOS PATHOGENS (2012)
Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies
Sajal K. Ghosh et al.
ADVANCES IN VIROLOGY (2012)
STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma
Lorand L. Kis et al.
BLOOD (2011)
Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas
Katerina Vrzalikova et al.
BLOOD (2011)
Cumulative Incidence of Cancer Among Individuals With Acquired Immunodeficiency Syndrome in the United States
Edgar P. Simard et al.
CANCER (2011)
Cytotoxic CD4+ T Cell Responses to EBV Contrast with CD8 Responses in Breadth of Lytic Cycle Antigen Choice and in Lytic Cycle Recognition
Heather M. Long et al.
JOURNAL OF IMMUNOLOGY (2011)
The Epstein-Barr Virus-Encoded BILF1 Protein Modulates Immune Recognition of Endogenously Processed Antigen by Targeting Major Histocompatibility Complex Class I Molecules Trafficking on both the Exocytic and Endocytic Pathways
Jianmin Zuo et al.
JOURNAL OF VIROLOGY (2011)
Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression
Seiji Maruo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin
Jie Lu et al.
VIROLOGY (2011)
HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells
Andrew Prendergast et al.
AIDS (2010)
Genome wide DNA-profiling of HIV-related B-cell lymphomas
Daniela Capello et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Constitutive Canonical NF-κB Activation Cooperates with Disruption of BLIMP1 in the Pathogenesis of Activated B Cell-like Diffuse Large Cell Lymphoma
Dinis Pedro Calado et al.
CANCER CELL (2010)
BLIMP1 Is a Tumor Suppressor Gene Frequently Disrupted in Activated B Cell-like Diffuse Large B Cell Lymphoma
Jonathan Mandelbaum et al.
CANCER CELL (2010)
Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia
Olaf Merkel et al.
CELL CYCLE (2010)
Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets
Manuel Guerreiro et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Epstein-Barr virus positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations
Sylvia Hoeller et al.
HUMAN PATHOLOGY (2010)
HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma
Marta Epeldegui et al.
IMMUNOLOGIC RESEARCH (2010)
AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome
Markus Kalla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Structural Basis for Apoptosis Inhibition by Epstein-Barr Virus BHRF1
Marc Kvansakul et al.
PLOS PATHOGENS (2010)
Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome
Bruno Chetaille et al.
BLOOD (2009)
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes
Patrick J. Hanley et al.
BLOOD (2009)
Crystal Structure of Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1
Kazutaka Murayama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Highly Active Antiretroviral Therapy and the Incidence of Non-AIDS-Defining Cancers in People With HIV Infection
Thomas Powles et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Down-Regulation of MHC Class II Expression through Inhibition of CIITA Transcription by Lytic Transactivator Zta during Epstein-Barr Virus Reactivation
Dan Li et al.
JOURNAL OF IMMUNOLOGY (2009)
Specific Targeting of the EBV Lytic Phase Protein BNLF2a to the Transporter Associated with Antigen Processing Results in Impairment of HLA Class I-Restricted Antigen Presentation
Danielle Horst et al.
JOURNAL OF IMMUNOLOGY (2009)
Primary B-Cell Infection with a ΔBALF4 Epstein-Barr Virus Comes to a Halt in the Endosomal Compartment yet Still Elicits a Potent CD4-Positive Cytotoxic T-Cell Response
Bernhard Neuhierl et al.
JOURNAL OF VIROLOGY (2009)
The Epstein-Barr Virus Alkaline Exonuclease BGLF5 Serves Pleiotropic Functions in Virus Replication
R. Feederle et al.
JOURNAL OF VIROLOGY (2009)
Early Events Associated with Infection of Epstein-Barr Virus Infection of Primary B-Cells
Sabyasachi Halder et al.
PLOS ONE (2009)
Clinical Characteristics and Outcome of Children With Burkitt Lymphoma in Uganda According to HIV Infection
Jackson Orem et al.
PEDIATRIC BLOOD & CANCER (2009)
The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim
Anthony L. Desbien et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation
Lesley Rees et al.
TRANSPLANTATION (2009)
The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation
Jianmin Zuo et al.
PLOS PATHOGENS (2009)
Degradation of Phosphorylated p53 by Viral Protein-ECS E3 Ligase Complex
Yoshitaka Sato et al.
PLOS PATHOGENS (2009)
EBV and HIV-Related Lymphoma
Michele Bibas et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2009)
Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates up-regulation of CCL20 and the migration of regulatory T cells
Karl R. N. Baumforth et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: Special references to lymphomas surrounding this newly recognized clinicopathologic disease
Yoshie Shimoyama et al.
CANCER SCIENCE (2008)
Epstein-Barr virus nuclear antigen-1 renders lymphocytes responsive to IL-2 but not IL-15 for survival
Penelope Tsimbourri et al.
JOURNAL OF GENERAL VIROLOGY (2008)
EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets:: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines
Tracey A. Haigh et al.
JOURNAL OF IMMUNOLOGY (2008)
Relationship between T cell activation and CD4(+) T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy
Peter W. Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-γ
Till Strowig et al.
PLOS PATHOGENS (2008)
Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction
Daniel E. Kaufmann et al.
NATURE IMMUNOLOGY (2007)
Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/P13-K/Akt pathway
Makoto Fukuda et al.
JOURNAL OF VIROLOGY (2007)
Age-related EBV-Associated B-Cell Lymphoproliferative disorders constitute a distinct clinicopathologic group: A study of 96 patients
Takashi Oyama et al.
CLINICAL CANCER RESEARCH (2007)
A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates
Andrew D. Hislop et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults
Michel Moutschen et al.
VACCINE (2007)
Chronic herpesvirus reactivation occurs in aging
Raymond P. Stowe et al.
EXPERIMENTAL GERONTOLOGY (2007)
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies
Susan R. Perrine et al.
BLOOD (2007)
Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion
Martin Rowe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes
Wangrong Wen et al.
JOURNAL OF VIROLOGY (2007)
Genomic imbalances in AIDS-related lymphomas:: relation with tumoral Epstein-Barr virus status
Parissa Vaghefi et al.
AIDS (2006)
Mucosal but not peripheral FOYP3+ regulatory T cells are highly increased in untreated HIV infection and nonnalize after suppressive HAART
Hans-Joerg Epple et al.
BLOOD (2006)
Low CD4+ T-cell counts in HIV patients receiving effective antiretroviral therapy are associated with CD4+ T-cell activation and senescence but not with lower effector memory T-cell function
Sonia Fernandez et al.
CLINICAL IMMUNOLOGY (2006)
Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins
D Adhikary et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
NF-κB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo
SA Keller et al.
BLOOD (2006)
Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A
CA Moody et al.
JOURNAL OF VIROLOGY (2005)
EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX
T Grimm et al.
BLOOD (2005)
The immune response to primary EBV infection: a role for natural killer cells
H Williams et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1: Implications for EBV-mediated immortalization
V Saridakis et al.
MOLECULAR CELL (2005)
CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines
HM Long et al.
JOURNAL OF VIROLOGY (2005)
Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR
A Dutton et al.
JOURNAL OF PATHOLOGY (2005)
Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells
D Hochberg et al.
JOURNAL OF VIROLOGY (2004)
Role of NF-κB in cell survival and transcription of latent membrane protein 1 -: Expressing or Epstein-Barr virus latency III-infected cells
ED Cahir-McFarland et al.
JOURNAL OF VIROLOGY (2004)
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
JM Brenchley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract
S Mehandru et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Immune activation set point during early FHV infection predicts subsequent CD4+ T-cell changes independent of viral load
SG Deeks et al.
BLOOD (2004)
Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients
L Weiss et al.
BLOOD (2004)
Persistent immune activation in HIV-1 infection is associated with progression to AIDS
MD Hazenberg et al.
AIDS (2003)
Combination Antiretroviral therapy results in a rapid increase in T cell receptor variable region β repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children
ZC Kou et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection
B Neuhierl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8+ T-cell restoration
P Porcu et al.
BLOOD (2002)
Cytokine production and cytolytic mechanism of CD4+ cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures
Q Sun et al.
BLOOD (2002)
The dispersal of mucosal memory B cells: Evidence from persistent EBV infection
LL Laichalk et al.
IMMUNITY (2002)
Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins
DS Bellows et al.
JOURNAL OF VIROLOGY (2002)
Differential evolution and stability of epitope-specific CD8+ T cell responses in EBV infection
MD Catalina et al.
JOURNAL OF IMMUNOLOGY (2001)
Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4+ T-helper 1 responses
A Leen et al.
JOURNAL OF VIROLOGY (2001)
Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells
A Khanolkar et al.
VIROLOGY (2001)
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
K Bickham et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Non-Hodgkin lymphoma in Uganda: a case-control study
DM Parkin et al.
AIDS (2000)
The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators
R Feederle et al.
EMBO JOURNAL (2000)
Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter
L Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
